Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Apr;95(4):1464–1471. doi: 10.1172/JCI117817

24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations.

J Sturis 1, A J Scheen 1, R Leproult 1, K S Polonsky 1, E van Cauter 1
PMCID: PMC295628  PMID: 7706450

Abstract

Under basal and stimulated conditions, normal insulin secretion oscillates with periods in the ultradian 100-150-min range. To test the hypothesis that oscillatory insulin delivery is more efficient in reducing blood glucose levels than continuous administration, nine normal young men were each studied on two occasions during a 28-h period including a period of polygraphically recorded sleep. Endogenous insulin secretion was suppressed by somatostatin, a constant intravenous glucose infusion was administered, and exogenous insulin was infused either at a constant rate or in a sinusoidal pattern with a period of 120 min. The mean glucose level over the 28-h period was 0.72 +/- 0.31 mmol/liter lower when insulin was infused in an oscillatory pattern than when the rate of infusion was constant (P < 0.05). The greater hypoglycemic effect of oscillatory versus constant infusion was particularly marked during the daytime, with the difference averaging 1.04 +/- 0.38 mmol/liter (P < 0.03). Serum insulin levels tended to be lower during oscillatory than constant infusion, although the same amount of exogenous insulin was administered under both conditions. Ultradian insulin oscillations appear to promote more efficient glucose utilization.

Full text

PDF
1464

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belchetz P. E., Plant T. M., Nakai Y., Keogh E. J., Knobil E. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science. 1978 Nov 10;202(4368):631–633. doi: 10.1126/science.100883. [DOI] [PubMed] [Google Scholar]
  2. Bolli G. B., De Feo P., De Cosmo S., Perriello G., Ventura M. M., Calcinaro F., Lolli C., Campbell P., Brunetti P., Gerich J. E. Demonstration of a dawn phenomenon in normal human volunteers. Diabetes. 1984 Dec;33(12):1150–1153. doi: 10.2337/diab.33.12.1150. [DOI] [PubMed] [Google Scholar]
  3. Bolli G. B., Gerich J. E. The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med. 1984 Mar 22;310(12):746–750. doi: 10.1056/NEJM198403223101203. [DOI] [PubMed] [Google Scholar]
  4. Bowden C. R., Bergman R. N., Marsh D. J. Cause of glucose oscillations during glucose infusion: periodic variation in glucose uptake. Am J Physiol. 1980 Apr;238(4):E395–E407. doi: 10.1152/ajpendo.1980.238.4.E395. [DOI] [PubMed] [Google Scholar]
  5. Bratusch-Marrain P. R., Komjati M., Waldhäusl W. K. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans. Diabetes. 1986 Aug;35(8):922–926. doi: 10.2337/diab.35.8.922. [DOI] [PubMed] [Google Scholar]
  6. Campbell P. J., Bolli G. B., Cryer P. E., Gerich J. E. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion. N Engl J Med. 1985 Jun 6;312(23):1473–1479. doi: 10.1056/NEJM198506063122302. [DOI] [PubMed] [Google Scholar]
  7. DeFronzo R. A., Ferrannini E. Regulation of hepatic glucose metabolism in humans. Diabetes Metab Rev. 1987 Apr;3(2):415–459. doi: 10.1002/dmr.5610030204. [DOI] [PubMed] [Google Scholar]
  8. Faber O. K., Binder C., Markussen J., Heding L. G., Naithani V. K., Kuzuya H., Blix P., Horwitz D. L., Rubenstein A. H. Characterization of seven C-peptide antisera. Diabetes. 1978;27 (Suppl 1):170–177. doi: 10.2337/diab.27.1.s170. [DOI] [PubMed] [Google Scholar]
  9. Hansen B. C., Jen K. C., Belbez Pek S., Wolfe R. A. Rapid oscillations in plasma insulin, glucagon, and glucose in obese and normal weight humans. J Clin Endocrinol Metab. 1982 Apr;54(4):785–792. doi: 10.1210/jcem-54-4-785. [DOI] [PubMed] [Google Scholar]
  10. Hastings M. H. Neuroendocrine rhythms. Pharmacol Ther. 1991;50(1):35–71. doi: 10.1016/0163-7258(91)90072-t. [DOI] [PubMed] [Google Scholar]
  11. Jaspan J. B., Lever E., Polonsky K. S., Van Cauter E. In vivo pulsatility of pancreatic islet peptides. Am J Physiol. 1986 Aug;251(2 Pt 1):E215–E226. doi: 10.1152/ajpendo.1986.251.2.E215. [DOI] [PubMed] [Google Scholar]
  12. Kraegen E. W., Young J. D., George E. P., Lazarus L. Oscillations in blood glucose and insulin after oral glucose. Horm Metab Res. 1972 Nov;4(6):409–413. doi: 10.1055/s-0028-1094019. [DOI] [PubMed] [Google Scholar]
  13. Lang D. A., Matthews D. R., Peto J., Turner R. C. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med. 1979 Nov 8;301(19):1023–1027. doi: 10.1056/NEJM197911083011903. [DOI] [PubMed] [Google Scholar]
  14. Lee A., Ader M., Bray G. A., Bergman R. N. Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes. 1992 Jun;41(6):750–759. doi: 10.2337/diab.41.6.750. [DOI] [PubMed] [Google Scholar]
  15. Marsh B. D., Marsh D. J., Bergman R. N. Oscillations enhance the efficiency and stability of glucose disposal. Am J Physiol. 1986 May;250(5 Pt 1):E576–E582. doi: 10.1152/ajpendo.1986.250.5.E576. [DOI] [PubMed] [Google Scholar]
  16. Matthews D. R., Lang D. A., Burnett M. A., Turner R. C. Control of pulsatile insulin secretion in man. Diabetologia. 1983 Apr;24(4):231–237. doi: 10.1007/BF00282705. [DOI] [PubMed] [Google Scholar]
  17. Matthews D. R., Naylor B. A., Jones R. G., Ward G. M., Turner R. C. Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes. 1983 Jul;32(7):617–621. doi: 10.2337/diab.32.7.617. [DOI] [PubMed] [Google Scholar]
  18. O'Meara N. M., Sturis J., Van Cauter E., Polonsky K. S. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. J Clin Invest. 1993 Jul;92(1):262–271. doi: 10.1172/JCI116560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ookhtens M., Marsh D. J., Smith S. W., Bergman R. N., Yates F. E. Fluctuations of plasma glucose and insulin in conscious dogs receiving glucose infusions. Am J Physiol. 1974 Apr;226(4):910–919. doi: 10.1152/ajplegacy.1974.226.4.910. [DOI] [PubMed] [Google Scholar]
  20. Paolisso G., Scheen A. J., Giugliano D., Sgambato S., Albert A., Varricchio M., D'Onofrio F., Lefèbvre P. J. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab. 1991 Mar;72(3):607–615. doi: 10.1210/jcem-72-3-607. [DOI] [PubMed] [Google Scholar]
  21. Polonsky K. S., Given B. D., Hirsch L. J., Tillil H., Shapiro E. T., Beebe C., Frank B. H., Galloway J. A., Van Cauter E. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 May 12;318(19):1231–1239. doi: 10.1056/NEJM198805123181903. [DOI] [PubMed] [Google Scholar]
  22. Polonsky K. S., Given B. D., Van Cauter E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 1988 Feb;81(2):442–448. doi: 10.1172/JCI113339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Polonsky K. S., Licinio-Paixao J., Given B. D., Pugh W., Rue P., Galloway J., Karrison T., Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest. 1986 Jan;77(1):98–105. doi: 10.1172/JCI112308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Robbins D. C., Jaspan J., Vasquez B., Van Cauter E. Biphasic patterns of peripheral insulin and glucose levels after lunch in normal subjects. Diabetes Care. 1987 May-Jun;10(3):293–299. doi: 10.2337/diacare.10.3.293. [DOI] [PubMed] [Google Scholar]
  25. Shapiro E. T., Tillil H., Polonsky K. S., Fang V. S., Rubenstein A. H., Van Cauter E. Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose. J Clin Endocrinol Metab. 1988 Aug;67(2):307–314. doi: 10.1210/jcem-67-2-307. [DOI] [PubMed] [Google Scholar]
  26. Simon C., Brandenberger G., Follenius M. Absence of the dawn phenomenon in normal subjects. J Clin Endocrinol Metab. 1988 Jul;67(1):203–205. doi: 10.1210/jcem-67-1-203. [DOI] [PubMed] [Google Scholar]
  27. Simon C., Brandenberger G., Follenius M., Schlienger J. L. Alteration in the temporal organisation of insulin secretion in type 2 (non-insulin-dependent) diabetic patients under continuous enteral nutrition. Diabetologia. 1991 Jun;34(6):435–440. doi: 10.1007/BF00403183. [DOI] [PubMed] [Google Scholar]
  28. Simon C., Brandenberger G., Follenius M. Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition. J Clin Endocrinol Metab. 1987 Apr;64(4):669–674. doi: 10.1210/jcem-64-4-669. [DOI] [PubMed] [Google Scholar]
  29. Simon C., Follenius M., Brandenberger G. Postprandial oscillations of plasma glucose, insulin and C-peptide in man. Diabetologia. 1987 Oct;30(10):769–773. doi: 10.1007/BF00275742. [DOI] [PubMed] [Google Scholar]
  30. Sonnenberg G. E., Hoffman R. G., Mueller R. A., Kissebah A. H. Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes. 1994 Mar;43(3):468–477. doi: 10.2337/diab.43.3.468. [DOI] [PubMed] [Google Scholar]
  31. Sonnenberg G. E., Hoffmann R. G., Johnson C. P., Kissebah A. H. Low- and high-frequency insulin secretion pulses in normal subjects and pancreas transplant recipients: role of extrinsic innervation. J Clin Invest. 1992 Aug;90(2):545–553. doi: 10.1172/JCI115893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Soybel D., Jaspan J., Polonsky K., Goldberg I., Rayfield E., Tager H. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies. J Clin Endocrinol Metab. 1983 Mar;56(3):612–618. doi: 10.1210/jcem-56-3-612. [DOI] [PubMed] [Google Scholar]
  33. Sturis J., O'Meara N. M., Shapiro E. T., Blackman J. D., Tillil H., Polonsky K. S., Van Cauter E. Differential effects of glucose stimulation upon rapid pulses and ultradian oscillations of insulin secretion. J Clin Endocrinol Metab. 1993 Apr;76(4):895–901. doi: 10.1210/jcem.76.4.8473402. [DOI] [PubMed] [Google Scholar]
  34. Sturis J., Polonsky K. S., Shapiro E. T., Blackman J. D., O'Meara N. M., van Cauter E. Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1992 Jul;35(7):681–689. doi: 10.1007/BF00400263. [DOI] [PubMed] [Google Scholar]
  35. Sturis J., Van Cauter E., Blackman J. D., Polonsky K. S. Entrainment of pulsatile insulin secretion by oscillatory glucose infusion. J Clin Invest. 1991 Feb;87(2):439–445. doi: 10.1172/JCI115015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Van Cauter E., Blackman J. D., Roland D., Spire J. P., Refetoff S., Polonsky K. S. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest. 1991 Sep;88(3):934–942. doi: 10.1172/JCI115396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Van Cauter E., Désir D., Decoster C., Féry F., Balasse E. O. Nocturnal decrease in glucose tolerance during constant glucose infusion. J Clin Endocrinol Metab. 1989 Sep;69(3):604–611. doi: 10.1210/jcem-69-3-604. [DOI] [PubMed] [Google Scholar]
  38. Van Cauter E. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am J Physiol. 1988 Jun;254(6 Pt 1):E786–E794. doi: 10.1152/ajpendo.1988.254.6.E786. [DOI] [PubMed] [Google Scholar]
  39. Van Cauter E., Mestrez F., Sturis J., Polonsky K. S. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992 Mar;41(3):368–377. doi: 10.2337/diab.41.3.368. [DOI] [PubMed] [Google Scholar]
  40. Verdin E., Castillo M., Luyckx A. S., Lefebvre P. J. Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man. Diabetes. 1984 Dec;33(12):1169–1174. doi: 10.2337/diab.33.12.1169. [DOI] [PubMed] [Google Scholar]
  41. Verrillo A., De Teresa A., Martino C., Di Chiara G., Pinto M., Verrillo L., Torello F., Gattoni A. Differential roles of splanchnic and peripheral tissues in determining diurnal fluctuation of glucose tolerance. Am J Physiol. 1989 Oct;257(4 Pt 1):E459–E465. doi: 10.1152/ajpendo.1989.257.4.E459. [DOI] [PubMed] [Google Scholar]
  42. Zhong P., Cara J. F., Tager H. S. Importance of receptor occupancy, concentration differences, and ligand exchange in the insulin-like growth factor I receptor system. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11451–11455. doi: 10.1073/pnas.90.24.11451. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES